Technology News and Research

RSS

Simcere Pharmaceutical first-quarter total revenue up 3.7% to $67.2 million

Simcere Pharmaceutical Group, a leading pharmaceutical company specializing in the development, manufacturing, and marketing of branded generic and proprietary pharmaceuticals in China, today reported preliminary unaudited financial results for the quarter ended March 31, 2010.

18 May 2010

IDEV launches SUPERA VERITAS Peripheral Vascular System in Europe

IDEV Technologies, Incorporated, (IDEV) an emerging leader in the development and marketing of minimally invasive medical technologies, today announced the European launch of the SUPERA VERITAS™ Peripheral Vascular System, a novel and innovative stent delivery system designed to be reliable, easy to use and precise. The SUPERA VERITAS system was formally launched in the first quarter of 2010 at the Leipzig Interventional Course (LINC) 2010 conference in Leipzig, Germany.

18 May 2010

Vect-Horus accentuates its leadership in delivering drugs to the central nervous system

Vect-Horus is a biotechnology company based on the scientific work of Dr. Michel Khrestchatisky and specializes in the development of peptide and pseudo-peptide-based vector molecules for drug targeting and delivery to the central nervous system (CNS).

18 May 2010

New DVS radiation measurement device for prostate cancer treatment

John Theurer Cancer Center at Hackensack University Medical Center announced today that it is one of two cancer centers in the tri-state area currently implanting a wireless radiation sensor, known as DVS. John Theurer Cancer Center radiation oncologists can now receive data immediately post- treatment on the precise amount of radiation being delivered to tumors and surrounding tissue for prostate cancer treatments.

18 May 2010

Helicos BioSciences to focus business on diagnostics markets

Helicos BioSciences Corporation announced today that, as part of the Company's previously disclosed efforts to consider alternatives to its existing long-term strategy, it is in the process of implementing a strategic shift to focus the business on the diagnostics markets. In connection with this effort, the Company has committed to a consolidation and reorganization of its operations in order to reduce operating costs.

18 May 2010

Abviva receives Japanese patent for Mammastatin Serum Assay

Abviva, Inc., a biomedical company engaged in the development and commercialization of breast cancer related applications of Mammastatin, announced today that the Japanese Patent Office issued two patents on the core technology that may be used for therapeutic applications and in the Company's breast cancer risk assessment test, the Mammastatin Serum Assay (MSA).

18 May 2010

Remote Presence hospital networks to accelerate patient's access to clinical stroke experts

InTouch Health, the world leader in Remote Presence Total Telemedicine solutions, is advancing stroke care by developing Remote Presence hospital networks that accelerate a patient's access to clinical stroke experts. To date, the Company has more than 25 stroke and multispecialty care networks comprised of over 300 hospital locations.

18 May 2010

BioSante receives two new US patents covering 2A/Furin technology for expressing proteins

BioSante Pharmaceuticals, Inc. today announced the receipt of two US new patents directed to its 2A/Furin technology for expressing proteins. The first issued US patent, US Pat. No., 7,709,224, covers methods for manufacturing recombinant antibodies. By incorporating our 2A/Furin technology into antibody-expression in viral vectors it is possible to rapidly generate stable, high producing antibody cell lines.

18 May 2010

Launch Diagnostics to distribute MDI's Detect-Ready MRSA assay in UK, France and Republic of Ireland

Molecular Detection Inc. (MDI), a company developing Detect-Ready™ assays designed to increase the speed and accuracy of infectious disease diagnosis, and Launch Diagnostics Ltd. today announced an exclusive distribution agreement for MDI's Detect-Ready MRSA assay in the UK, France and Republic of Ireland.

18 May 2010

Pfizer, Washington University announce indications discovery collaboration

In a first-of-a-kind collaboration between academia and industry, Pfizer Inc. will give scientists at Washington University School of Medicine in St. Louis unprecedented access to information regarding more than 500 pharmaceuticals and pharmaceutical candidates in a partnership that focuses on discovering new uses for existing compounds.

18 May 2010

Biotage to acquire extraction, evaporation product lines for Sample Preparation from Caliper Life Sciences

Biotage AB, a global leader in tools and technology for medicinal and analytical chemistry, and Caliper Life Sciences, Inc. today announces a transaction under which Biotage is acquiring extraction and evaporation product lines for Sample Preparation from Caliper.

18 May 2010

Sutter Health Sac-Sierra Region selects MedAssets' CarePricer patient bill estimation solution

The Sacramento Sierra Region of Sutter Health has selected MedAssets' patient bill estimation solution, CarePricer®, to provide its patients with accurate Patient Friendly Estimates™ at the point-of-access. Using the solution, Sutter Health's seven hospitals in the region will better educate its patients on their responsibilities upfront to improve collections.

18 May 2010

Sonova Group financial year 2009/10 sales increase 20.1% to CHF 1,500.3 million

The Sonova Group increased its sales in financial year 2009/10 to CHF 1,500.3 million from CHF 1,249.2 million, thus posting an excellent growth rate of 20.1% in Swiss francs, despite a negative currency effect of 3.7%. The Group achieved organic growth of 18.4% in local currencies, which significantly surpassed the market as a whole. Market growth in 2009/10 is estimated at around 4% in units sold.

18 May 2010

Patients who receive H-SRT for recurrent brain cancer live longer: Researchers

Patients who received hypofractionated stereotactic radiotherapy for their recurrent brain cancers lived longer lives, according to researchers at Thomas Jefferson University.

18 May 2010

Covidien introduces EEA Hemorrhoid & Prolapse Stapler Set with DST Series Technology

Covidien, a leading global provider of healthcare products, today announced that it is entering the hemorrhoidopexy market for the first time with EEATM Hemorrhoid & Prolapse Stapler Set with DST SeriesTM Technology.

18 May 2010

N-Viro International first-quarter net loss increases to $1.14M, or $0.22 per share

N-Viro International Corporation, a leading-edge environmental biotech company that markets an alternative fuel technology and advanced fertilizer products, including the renewable biofuel N-Viro Fuel™ and N-Viro Soil™, announced that on May 17, 2010 it filed its Quarterly Report on Form 10-Q for the three months ended March 31, 2010.

18 May 2010

MorphoSys AG (DE) - AbD Serotec enters new growth area

MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that its research and diagnostic antibody unit AbD Serotec is active in a new growth area.

18 May 2010

Health Discovery receives MICO Award from MDB Capital at Bright Lights Conference

Health Discovery Corporation announced today it received the prestigious MICO Award presented by MDB Capital Group, San Francisco, Calif., at its invitation-only Bright Lights Conference held May 11-12, 2010. Health Discovery Corporation was chosen from among 1,600 publicly traded, small cap companies.

18 May 2010

Sonablate HIFU treatment now available in Bermuda for patients with prostate cancer

US HIFU, a worldwide leader in the development, distribution and use of minimally invasive high intensity focused ultrasound technologies, is pleased to announce that its HIFU treatment for prostate cancer is now available in Bermuda. King Edward VII Memorial Hospital in Bermuda joins more than 100 centers in 30-plus countries to offer the innovative treatment with the Sonablate 500 medical device.

18 May 2010

Inovio Pharmaceuticals first-quarter net loss attributable to common stockholders decreases to $2.3M

Inovio Pharmaceuticals, Inc. today reported financial results for the quarter ended March 31, 2010.

18 May 2010

Technology News and Research

Simcere Pharmaceutical first-quarter total revenue up 3.7% to $67.2 million

IDEV launches SUPERA VERITAS Peripheral Vascular System in Europe

Vect-Horus accentuates its leadership in delivering drugs to the central nervous system

New DVS radiation measurement device for prostate cancer treatment

Helicos BioSciences to focus business on diagnostics markets

Abviva receives Japanese patent for Mammastatin Serum Assay

Remote Presence hospital networks to accelerate patient's access to clinical stroke experts

BioSante receives two new US patents covering 2A/Furin technology for expressing proteins

Launch Diagnostics to distribute MDI's Detect-Ready MRSA assay in UK, France and Republic of Ireland

Pfizer, Washington University announce indications discovery collaboration

Biotage to acquire extraction, evaporation product lines for Sample Preparation from Caliper Life Sciences

Sutter Health Sac-Sierra Region selects MedAssets' CarePricer patient bill estimation solution

Sonova Group financial year 2009/10 sales increase 20.1% to CHF 1,500.3 million

Patients who receive H-SRT for recurrent brain cancer live longer: Researchers

Covidien introduces EEA Hemorrhoid & Prolapse Stapler Set with DST Series Technology

N-Viro International first-quarter net loss increases to $1.14M, or $0.22 per share

MorphoSys AG (DE) - AbD Serotec enters new growth area

Health Discovery receives MICO Award from MDB Capital at Bright Lights Conference

Sonablate HIFU treatment now available in Bermuda for patients with prostate cancer

Inovio Pharmaceuticals first-quarter net loss attributable to common stockholders decreases to $2.3M

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News